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Selective citation in scientific literature on
the human health effects of bisphenol A
M. J. E. Urlings1* , B. Duyx1, G. M. H. Swaen1, L. M. Bouter2,3 and M. P. Zeegers1,4
Abstract
Introduction: Bisphenol A is highly debated and studied in relation to a variety of health outcomes. This large
variation in the literature makes BPA a topic that is prone to selective use of literature, in order to underpin one’s
own findings and opinion. Over time, selective use of literature, by means of citations, can lead to a skewed
knowledge development and a biased scientific consensus. In this study, we assess which factors drive citation and
whether this results in the overrepresentation of harmful health effects of BPA.
Methods: A citation network analysis was performed to test various determinants of citation. A systematic search
identified all relevant publications on the human health effect of BPA. Data were extracted on potential
determinants of selective citation, such as study outcome, study design, sample size, journal impact factor, authority
of the author, self-citation, and funding source. We applied random effect logistic regression to assess whether
these determinants influence the likelihood of citation.
Results: One hundred sixty-nine publications on BPA were identified, with 12,432 potential citation pathways of
which 808 citations occurred. The network consisted of 63 cross-sectional studies, 34 cohort studies, 29 case-control
studies, 35 narrative reviews, and 8 systematic reviews. Positive studies have a 1.5 times greater chance of being
cited compared to negative studies. Additionally, the authority of the author and self-citation are consistently found
to be positively associated with the likelihood of being cited. Overall, the network seems to be highly influenced by
two highly cited publications, whereas 60 out of 169 publications received no citations.
Conclusion: In the literature on BPA, citation is mostly driven by positive study outcome and author-related factors,
such as high authority within the network. Interpreting the impact of these factors and the big influence of a few
highly cited publications, it can be questioned to which extent the knowledge development in human literature on
BPA is actually evidence-based.
Keywords: Questionable research practice, Selective citation, Citation analysis, Methodology, Bisphenol A
Introduction
Bisphenol A (BPA) is a chemical substance, which is
used in plastics of, for example, food containers and can
linings. It is considered a potential endocrine disruptor,
as it might bind to estrogen receptors in the body and
mimic estrogen’s function [1]. Most research of the po-
tential harmful effects of BPA and its underlying mech-
anism has been conducted using in vitro studies or
animal models [2]. In the in vitro setting, it was found
that BPA can directly bind to androgen receptors and
thereby block endogenous androgen action [3]. Because
of its various uses, exposure to BPA in humans is wide-
spread. Epidemiological studies linked exposure to BPA
to a large variety of health outcomes, such as reproduct-
ive outcomes, metabolic diseases, behavioral outcomes,
and intermediate health effects (e.g., DNA methylation
and oxidative stress) [2, 4–6]. In 2012, the WHO con-
cluded that the epidemiological evidence with respect to
human health effects of BPA is limited and not coherent
across the different health outcomes [7]. Additionally,
the European Food Safety Authority has concluded that
there is no health concern for humans at the expected
level of intake [8]. In 2006, EFSA has set a tolerable daily
intake (TDI) level of 0.05 mg per kilogram body weight
per day [8]. This TDI is based on a no observed adverse
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effect level (NOAEL) determined in rodent studies and
is also accepted in other countries, such as the USA and
Japan [9]. BPA has not only been debated in the scien-
tific community. It has also been a topic of extensive
public debate, in which different stakeholders are in-
volved such as industry and non-governmental organiza-
tions [10, 11]. The public discussion on the health risks
of BPA, combined with the variety of BPA health effects,
makes it a topic that is vulnerable to the distored use of
evidence.. Especially when scientific evidence is the basis
for decision-making processes, such as setting maximum
levels of exposure, a complete and balanced view is cru-
cial. Therefore, it is important to understand the know-
ledge development in this field of research.
Scientific knowledge development to a large extent is
driven by citations. Due to the large and growing num-
ber of scientific publications in the biomedical domain
and the limitation of the maximum number of refer-
ences in many journals, it is often not feasible to refer to
all available relevant literature [12]. In many cases, it is
unclear on which grounds researchers decide to select
the articles they cite. Selecting references based on their
study results, usually meaning that positive studies are
cited more often than negative studies, is called citation
bias [13]. Citation bias has been studied in a variety of
research areas, by using different methodologies and
showing different results [14–17]. A recent systematic
review has identified 52 studies on citation bias, from
scientific disciplines in biomedical sciences, social sci-
ences, and natural sciences. Twenty-nine of them found
evidence for the existence of bias, whereas 12 studies
found mixed results and 11 studies did not find evidence
for the existence of citation bias [18]. Looking at the se-
lection of references in a broader sense, authors might
have different motives to select their references, which
can take the form of justified (e.g., the methodological
quality of a publication) or unjustified determinants
(e.g., study outcome) of selective citation. Determinants
that have been shown to be related to citation rate in
multiple studies are sample size, study design, journal
impact factors, and the number of references [19–21].
With regard to funding, it is often suggested that
for-profit funding is less credible because only results that
are preferred by the funder would be published [22]. A
study by Kulkarni et al. showed that industry-funded stud-
ies that reported industry-favorable results were indeed
associated with a higher annual citation count [23]. Fac-
tors that have been occasionally linked to citation count
are the gender of the author, the number and type of affili-
ations included in a publication, the authors’ reputation,
and whether the title of the publication includes its con-
clusion or not [19, 21]. It should be recognized that the ef-
fect of most determinants of selective citation will be
located somewhere on the sliding scale between justified
and unjustified determinants of citation with regard to
their effect on knowledge development. It is the focus of
the current study to identify which factors influence the
development of knowledge by means of selective citations.
The literature on BPA is used as a case study in this re-
gard, which we chose because of its controversial nature
and extensive public debate. Accordingly, we are not so
much interested in the actual health effect of BPA and we
will not make statements about this. For clarity reasons,
we take the hypothesis that BPA has a harmful effect on
human health as the starting point of this study.
The objective of this study is to assess the prevalence
and determinants of selective citation in human studies
on BPA in a quantitative manner.
Methods
The design of this study was described in a study proto-
col, which was finalized and published online prior to
the data collection (https://bit.ly/2kiDK4Z). The protocol
is also available as Additional file 1 to this publication.
The main steps of the citation network analysis will be
described in the following paragraphs.
Search strategy and article selection
All relevant publications were identified via Web of Sci-
ence Core Collections, on 3 March 2017. For practical
reasons, no other databases were searched, since only
the Web of Science Core Collections has the possibility
to download the reference lists of all publications. This
information is needed to create the citation network and
to perform the citation analysis. Identification of articles
by checking the reference lists was not applied, since this
would interfere with the research question. Checking
reference lists would result in an overrepresentation of
articles that are cited within the network, whereas arti-
cles that have been neglected by the network would still
be missed. To prevent missing important publications, a
broad search strategy was applied, namely (“Bisphenol
A” OR “BPA”) AND (“Human*”). No limitations with re-
gard to the health outcomes studied were applied.
The search strategy was very broad and not specific, in
order to avoid missing relevant publication. This led to a
large number of publications, namely 3412. The article
selection was carried out in two phases. The first selec-
tion round was based on the publication title, to limit
the number of publications. The second selection round
included studying abstracts, figures, and tables, to
finalize the network of human BPA studies. Many publi-
cations discussed BPA together with many other chem-
ical compounds. By looking only at the abstract, it was
not always clear to which extent the publication in-
cluded information on BPA. By looking also at the fig-
ures and tables, we could make sure the publication
contained sufficient information on BPA to be part of
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the network. The complete article selection was con-
ducted individually by two researchers, MJEU and BD,
followed by several consensus meetings. In case no con-
sensus could be reached, a third researcher (GMHS) was
asked to take a decision (Fig. 1).
Data extraction
All publications in the network were scrutinized for a
number of characteristics that may be potential determi-
nants of citation (see Table 1). Data extraction was per-
formed independently by MJEU and GMHS. In all cases,
consensus was reached. Study outcome was scored in
two ways. First, the data presented in the article were
scored according to the reported statistical significance
(statistically significant, not significant, or mixed). A
publication was scored statistically significant when the
primary study outcome reported a p value lower than
0.05. When multiple health outcomes were reported and
the data showed p values both higher and lower than
0.05, a publication was considered mixed. Narrative re-
views and systematic reviews without meta-analysis,
which do not present new data, were not scored on their
statistical significance. Secondly, the study outcome is
scored by studying the authors’ conclusion of the publi-
cation. This can be either in line or not in line with the
hypothesis that BPA has an adverse effect on human
health. The health outcomes studied in the network
were grouped into eight categories: reproductive out-
comes, metabolic diseases, intermediate health parame-
ters, hormone production, birth outcomes, behavioral
outcomes, cancer, and others. The journal impact factor
at the moment of publication was measured via the Web
of Science.
The determinant “authority of the corresponding au-
thor” was measured on the publication’s level and can
vary over time. All co-authors of all publications re-
ceived an “authority score,” which was the number of ci-
tations received within this BPA network, during each
year that the network was active. The authority of each
publication was determined by the co-author with the
highest authority score. We hypothesized that authors
with a high authority increased the credibility of a publi-
cation and therefore would lead to a higher likelihood of
being cited. Self-citation was defined as the situation in
which at least one author was listed on both the cited
and the citing publication.
Continuous determinants that show a large range of
values, which was often skewedly distributed, were di-
vided into three categories, in order to reduce the vari-
ation and create more meaningful outcomes. This
included the determinant’s sample size, journal impact
factor, authority of the author, number of references,
Fig. 1 Flow diagram of the network selection process
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Table 1 Characteristics of the bisphenol A network of 169 publications, 12,432 potential citation pathways and 808 realized citations
Variable Categories Number of publications Number of potential citation
pathways (% citations realized)
Study outcome
Statistical significance Yes 40 2800 (8%)
No 36 2813 (5%)
Mixed 47 3819 (9%)
Not reported 46 2800 (8%)
Authors’ conclusion In line with hypothesis 92 6826 (7%)
Not in line with hypothesis 28 2114 (4%)
Mixed 32 2658 (5%)
Unclear 17 834 (9%)
Content-related determinants
Health outcome Reproductive outcomes 49 3853 (7%)
Metabolic diseases 45 3218 (8%)
Intermediate health factors 24 1594 (2%)
Hormone production 18 1300 (8%)
Birth outcomes 11 971 (6%)
Behavioral outcomes 7 557 (3%)
Cancer 4 286 (2%)
Other 11 653 (6%)
Study design Cohort study 34 2471 (7%)
Cross-sectional study 63 5013 (9%)
Case-control study 29 2019 (4%)
Narrative review 35 2374 (4%)
Systematic review 8 555 (5%)
Sample size* < 168 42 3259 (6%)
168–430 42 3154 (6%)
> 430 43 3212 (10%)
Title of publication Suggestive of conclusion 33 2327 (5%)
Not suggestive of conclusion 136 10,105 (7%)
Not content-related determinants
Number of affilations* < 3 51 4241 (5%)
3–5 59 3445 (7%)
> 5 59 4746 (7%)
Journal impact factor* < 2.85 60 4188 (5%)
2.85–4.6 53 4210 (7%)
> 4.6 56 4034 (8%)
Funding source Not for profit 135 10,548 (7%)
For profit 0 0 (0%)
Both 4 369 (7%)
Funding not reported 20 968 (3%)
No funding applicable 10 547 (3%)
Number of references* < 46 65 4152 (7%)
46–58 47 4200 (8%)
> 58 57 4080 (5%)
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and number of affiliation. By making three categories for
each determinant, each publication scores low, medium,
or high in relation to the other publications in the net-
work. Cutoff points between categories were based on
tertiles, to make sure each category contained the same
number of publications.
Statistical analysis
Each publication in the network could take the role of
the citing and the cited publication. We were solely in-
terested in the effect of the characteristics of the cited
publication on the likelihood of being cited, and there-
fore, the unit of analysis was the potential citation path.
A potential citation path existed between one publica-
tion and every other publication in the network that was
available online at the moment of submission. In the
data set, each row represented a potential citation path
followed by an indication whether the potential citation
path had actually been realized or not and the character-
istics of the cited publication of that citation path.
A single publication normally references multiple
other publications, meaning that multiple citation path-
ways are leading to the same publication and are there-
fore not entirely independent. A multilevel approach
was therefore required, in which the citation paths were
nested under the citing publications. Random effect lo-
gistic regression was modeled to assess the effect of
characteristics of the cited article on the likelihood of
being cited.
First, univariate analyses were performed to test all po-
tential determinants of citation, described in the previous
paragraph, in the cited publication as a predictor for the
likelihood of being cited. Second, all analyses were ad-
justed for study design, which was considered a proxy for
study quality.
Additionally, we assessed whether concordance be-
tween the characteristics of the cited and citing publica-
tion was a determinant of citation. Via fixed effect
logistic regression analysis, we tested whether concord-
ance between the cited and citing publication deter-
mined the likelihood of citation. All statistical analyses
were performed in Stata 13.
The outcomes of the logistic regression are reported
as odds ratios. The odds ratio may overestimate the true
relative risk in studies where the outcome is common
[24]. In our network, the overall chance of being cited is
6.5% (808 actual citations of 12,432 potential citations).
With this incidence, we consider “being cited” not very
common, and consequently, the overestimation of the
true relative risk will be small [24]. Ultimately, the odds
ratio gives an accurate estimation of the direction of the
effect; only the exact magnitude of the effect should be
interpreted with some caution. For the sake of readabil-
ity of the publication, we interpret these values as if they
are relative risks and therefore, for instance, speak about
“the likelihood of being cited for negative studies com-
pared to positive studies.”
Results
A network of 169 publications on human effects of BPA
was identified, published between 2002 and the begin-
ning of 2017. The publications are connected by 12,432
potential citations, of which only 808 citations were ac-
tually realized, making the likelihood of being cited in
Table 1 Characteristics of the bisphenol A network of 169 publications, 12,432 potential citation pathways and 808 realized citations
(Continued)
Variable Categories Number of publications Number of potential citation
pathways (% citations realized)
Corresponding author-related determinants
Gender Male 86 7359 (7%)
Female 74 4472 (6%)
Unknown 9 601 (3%)
Affiliation University 136 10,403 (8%)
Government 14 925 (6%)
Industry 1 132 (1%)
Other 18 1152 (7%)
Continent America 73 6022 (8%)
Asia 47 3612 (5%)
Europe 42 2425 (4%)
Australia 1 35 (3%)
Africa 2 181 (2%)
Middle East 4 157 (0%)
*For descriptive purposes, continuous variables have been transformed to categories based on tertiles
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this network 6.5%. Figure 2 displays a visualization of a
part of the citation network, including the 100 most
cited publications. Each circle and square represents a
publication, with the squares being highly cited publica-
tions with more than 30 citations each. The lines indi-
cate a performed citation. On the y-axis, the timeline is
indicated, ranging from 2002 to 2017. The x-axis is
solely for visualization purposes.
Publication characteristics
Table 1 describes the distribution of the potential deter-
minants of citation over the publications in the network.
BPA was most frequently studied in relation to reproductive
outcomes (N= 49). The reproductive outcomes studied in-
cluded, among others, polycystic ovary syndrome, miscar-
riage, sperm quality, and in vitro fertilization implementation
failure. The study designs presented in this network were ob-
servational studies (experimental, cohort, cross-sectional, and
case-control studies), systematic reviews, and narrative re-
views. The network contains 126 publications that reported
empirical data, which were summarized in 43 review publica-
tions. None of the systematic reviews included a meta-ana-
lysis. Since the network contained only one experimental
study, this publication was classified as a cohort study. Look-
ing at the evidence on adverse effects of BPA on human
health, 40 publications reported statistically significant re-
sults, 36 publications reported non-significant results, and 47
publications reported mixed results. The authors of 92 publi-
cations concluded that there was a harmful effect of BPA on
human health. A mixed or unclear conclusion was drawn in
49 publications, against 28 publications that concluded there
was no harmful health effect of BPA. None of the studies
was funded solely by for-profit organizations, which made it
impossible to assess the effect of funding source as a deter-
minant of citation. This underrepresentation of private par-
ties in BPA research is also visible in the affiliation of the
corresponding authors. Corresponding authors of 136 publi-
cations are affiliated with university whereas only one corre-
sponding author is affiliated with industry.
Citation pattern
Although the first human BPA studies were published in
2002, the majority of the literature is published from
2010 onwards. Nevertheless, it seems that some of the
early studies attract a high number of citations. Two
publications, a narrative review published in 2007 and a
cross-sectional study published in 2008, received more
than 50 citations [25, 26]. On the other hand, 60 publi-
cations in the network received 0 citations, which led to
a very skewed distribution in the number of citations per
Fig. 2 Visualization of the citation network, depicting the 100 most cited studies in the network. The y-axis depicts the timeline of publications,
and the x-axis is solely for visualization purposes. Each circle and square is one publication, indicated by the name of the first author. The squares
are the four most cited publications in the network. Each line indicates a performed citation from one publication to another
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publication. The median number of citations per publi-
cation was 1.
Univariate and multivariate analyses (Table 2)
Study outcome, measured both as statistical significance
and as author conclusion in line with the hypothesis that
BPA is harmful to health, shows a significant positive asso-
ciation with the likelihood of citation. Significant and posi-
tive studies are approximately 1.5 times as likely to be
cited compared to negative and non-significant studies, an
effect that remains after the adjustment for study design.
The concordance analysis showed that the study outcome
was not likely to be concordant between the cited and cit-
ing publication (OR 1.06 (0.79–1.42), Additional file 2:
Table S1).
Contrary to our expectation, systematic reviews were
not more frequently cited than narrative reviews in the
full network. Sample size, number of affiliations, and
journal impact factor showed a moderate positive associ-
ation with the likelihood of being cited, with ORs be-
tween 1 and 2. These effects could partly be explained
by study design. The type of affiliation of the corresponding
Table 2 Univariate and multivariate analyses on potential determinants of the likelihood of being cited
Variable Categories Crude OR Adjusted OR*
Study outcome
Significance Yes vs no 1.57 (1.28–1.92) 1.48 (1.21–1.80)
Authors’ conclusion In line vs not in line with hypothesis 1.57 (1.29–1.92) 1.65 (1.34–2.03)
Content-related determinants
Study design Narrative review 1.00 (ref)
Cohort study 1.61 (1.26–2.07)
Cross-sectional study 2.00 (1.64–2.44)
Case-control study 1.08 (0.84–1.38)
Systematic review 1.36 (0.99–1.87)
Sample size ** < 168 1 (ref) 1.00 (ref)
168–430 1.04 (0.88–1.22) 1.00 (0.85–1.17)
> 430 1.62 (1.27–2.05) 1.39 (1.12–1.74)
Title of publication Suggestive title vs not suggestive title 1.25 (1.07–1.45) 1.16 (1.00–1.35)
Not content-related determinants
Number of affiliations** < 3 1.00 (ref) 1.00 (ref)
3–5 1.46 (1.22–1.75) 1.27 (1.04–1.56)
> 5 1.50 (1.24–1.82) 1.32 (1.06–1.65)
Journal Impact Factor** < 2.8 1.00 (ref) 1.00 (Ref)
2.8–4.6 1.21 (1.07–1.36) 1.08 (0.96–1.22)
> 4.6 1.41 (1.22–1.63) 1.22 (1.06–1.41)
Funding source For-profit vs not-for-profit *** NA NA
Not reported vs reported 0.41 (0.31–0.55) 0.74 (0.43–1.28)
Number of references** < 46 1.00(ref) 1.00 (ref)
46–58 1.24 (1.08–1.42) 1.10 (0.95–1.26)
> 58 0.75 (0.63–0.89) 0.78 (0.65–0.92)
Author-related determinants
Gender of corresponding author Male vs Female 1.00 (0.89–1.11) 0.97 (0.86–1.09)
Affiliation of corresponding author Private vs public sector 0.94 (0.75–1.17) 1.31 (0.57–3.01)
Authority of the authors** < 3 1.00 (ref) 1.00 (ref)
3–26 2.21 (1.84–2.66) 2.16 (1.78–2.63)
> 26 3.20 (2.59–3.96) 3.32 (2.64–4.18)
Self-citation Yes vs no 5.14 (3.88–6.81) 5.16 (3.81–6.99)
*Adjusted model is adjusted for study design
**Continuous variables were categorized based on tertiles
***None of the publications was funded solely by for-profit organizations, therefore this analysis was not possible
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author, gender of the corresponding author, report of fund-
ing, and number of references showed no association with
citation. Authority of the author and self-citation was found
to have the strongest association with the likelihood of being
cited. High authority, which was measured by a combination
of the number of publications and the number of earlier ci-
tations in this field, increased the likelihood of citation by
approximately three times. Authors were five times more
likely to cite their own work compared to that of others.
Sensitivity analysis
Knowing that the number of citations per publication is very
skewedly distributed, we tested to which extent the results
are driven by the two highly cited studies. As a data-driven,
post hoc analysis, we excluded these two studies, which re-
ceived more than 50 citations (Table 3). The significant ef-
fects that were found for the sample size and the number of
affiliations in the overall network disappeared. This can be
explained by the fact that one of the highly cited studies was
a cross-sectional study with a large sample size of 1455 par-
ticipants [26]. The other highly cited study was a narrative
review, which means the study had no specified sample size
[25]. Both studies were performed by relatively large research
groups of five and six affiliations, respectively. In this sensitiv-
ity analysis, the study outcome, journal impact factor, author-
ity of the author, and self-citation remained significantly
associated with citation.
Discussion
With this citation network analysis, we aimed to quan-
tify the occurrence of citation bias in the human BPA lit-
erature and the determinants that influence the citation
behavior in this field. Based on the finding that positive
studies have an approximately 1.5 higher likelihood of
Table 3 Sensitivity analysis: crude and adjusted odds ratios for the chance of being cited, excluding two highly cited publications
(> 50 citations)
Variable Categories Crude OR Adjusted OR*
Significance Yes vs no 1.57 (1.28–1.92) 1.48 (1.21–1.80)
Authors’ conclusion In line vs not in line with hypothesis 1.45 (1.18–1.77) 1.53 (1.25–1.87)
Study design Narrative review 1.00 (ref)
Cross-sectional study 4.44 (3.26–6.04)
Case-control study 2.61 (1.88–3.62)
Cohort study 3.93 (2.82–5.46)
Systematic review 3.28 (2.22–4.85)
Sample size** < 168 1.00 (ref) 1.00 (ref)
168–430 1.03 (0.87–1.21) 0.98 (0.84–1.16)
> 430 1.40 (1.09–1.79) 1.22 (0.97–1.54)
Title of publication Conclusive title vs non-conclusive title 1.07 (0.91–1.25) 0.96 (0.82–1.12)
Number of afilliations** < 3 1.00 (ref) 1.00 (ref)
3–5 1.46 (1.21–1.77) 1.06 (0.86–1.30)
> 5 1.09 (0.86–1.38) 0.70 (0.55–0.90)
Journal impact factor** < 2.8 1.00 (ref) 1.00 (ref)
2.8–4.6 1.62 (1.41–1.87) 1.38 (1.19–1.60)
> 4.6 1.59 (1.33–1.89) 1.43 (1.20–1.70)
Funding source Not reported vs reported 0.46 (0.34–0.63) 0.83 (0.62–1.13)
Number of references** < 46 1.00 (ref) 1.00 (ref)
46–58 1.07 (0.92–1.24) 0.96 (0.82–1.12)
> 58 0.51 (0.42–0.61) 0.56 (0.46–0.69)
Gender of corresponding author Male vs female 1.14 (1.01–1.28) 1.20 (1.05–1.37)
Affiliation of corresponding author Private vs public sector 1.07 (0.86–1.35) 1.08 (0.85–1.38)
Authority of the authors** < 3 1.00 (ref) 1.00 (ref)
3–26 2.26 (1.85–2.76) 2.09 (1.68–2.60)
> 26 2.75 (2.18–3.47) 2.69 (2.08–3.48)
Self-citation Yes vs no 5.46 (4.09–7.28) 5.05 (3.75–6.81)
*Adjusted model is adjusted for study design
**Continuous variables were categorized based on tertiles
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being cited compared to negative studies, we conclude
that citation bias is present in the BPA literature, al-
though its magnitude might be limited. This effect was
not confounded by study design and remained after ex-
cluding the most highly cited studies. Also, based on the
results from the concordance analysis, citation bias does
not appear to be influenced by the study outcome of the
citing publication.
These results are in line with the findings of a recent
meta-analysis on citation bias in various scientific fields,
of which most were biomedical [18]. This systematic re-
view and meta-analysis showed that citation bias is
prevalent throughout multiple biomedical research fields
and that significant findings lead to an approximately 1.5
times higher chance of citation compared to non-significant
findings [18]. This was a pooled effect over a variety of disci-
plines, such as Alzheimer’s disease, coronary heart disease,
and psychiatry [27–29]. Also, the finding that the authors’
conclusion has a stronger effect on citation than the signifi-
cance level of the data was confirmed by previous research
in this meta-analysis [18].
The second aim of this study was to assess the effect
of other potential determinants of citation. In the
complete network of 169 publications, sample size,
journal impact factor, the number of affiliations in-
volved, the authority of the author, and self-citation
were found to affect the likelihood of being cited. This
was in line with our expectations, based on previous re-
search in different research areas [30, 31]. However,
after the exclusion of the two publications with the
highest number of citations, only the journal impact
factor, authority of the authors, and occurrence of
self-citation appeared to be stable determinants of cit-
ation in the BPA literature. Different than the study
outcome influencing the likelihood of citation, the oc-
currence of self-citation is not necessarily leading to
biased knowledge development. To some extent,
self-citation is inevitable since academics are working
to expand on their previous work [32]. Of course, it
might lead to selective overrepresentation of certain re-
sults and their interpretation and thereby skew know-
ledge development [32]. Additionally, self-citation
might be a way for authors to promote their own vi-
sion, which might lead to an author-based instead of
evidence-based knowledge development. Before draw-
ing conclusions on the possible effect of self-citation on
knowledge development, we should keep in mind that
self-citations can be used in different ways, apart from
promoting certain results and substantiating an argu-
ment, authors refer to their own work to introduce a
method that was described earlier or to explain the
relevance of their research topic [33]. Based on the
current research, we could not conclude whether the
amount of self-citation leads to a biased knowledge
development in the BPA literature, since we did not
asses in which paragraph of the publication
self-citations were used.
In addition to the citation bias found, we should be
aware that a large proportion of the literature seems to
be completely ignored. More than one third of the publi-
cations receive zero citations, and even though these are
both positive and negative publications, it means that
part of the evidence is being left out of the picture and
researchers are not appreciated for their work. Looking
at the distribution of the number of citations per publi-
cation over time, it seems that the highly cited publica-
tions are early publications in the field. With the
growing amount of literature, the chance of not being
cited at all seems to increase. Although it is logical and
acceptable that founding publications are often men-
tioned to describe the research field, we should be aware
that the more recent evidence is less often referred to.
Especially because BPA is a research field that is highly
debated in risk assessment and risk management proce-
dures, it is important to have a complete overview of all
available evidence. The finding that a big part of litera-
ture is not valued in terms of citations has also been
found in other research fields [34–36]. For example,
Robinson and Goodman showed that in the field of clin-
ical trials, only a quarter of available trials got cited in
the development of a new trial. Also, the number of tri-
als that were cited did not increase with a bigger number
of available trials [34]. This gives support to the idea that
an abundance of literature leads to reduced visibility for
individual publications, potentially leading to research
waste and misinterpretation of the literature in
decision-making processes.
If we look, on the other hand, at the highly cited publi-
cations, it is remarkable that these studies have a narra-
tive review and a cross-sectional study design, both of
which are study designs that are typically not very highly
valued. Although we did not look into the content of the
publications in this study, we should be aware that both
studies do not give a complete overview of the literature,
as a systematic review would do, and thereby improve
the chance of skewed knowledge development.
One of the limitations of the current study is that the
search strategy was only applied to the Web of Science
Core Collection, making it quite possible that some rele-
vant publications have been missed. The search was lim-
ited to this database because Web of Science is the only
database that has the option to download the publica-
tions together with their reference lists. This information
was necessary to set up the database and perform the
statistical analysis. Nevertheless, we have no reason to
believe that the identified determinants of selective cit-
ation would be different if literature from other sources
would have been included in the network. A related
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limitation was the fact that we did not check reference
lists for missing publications. This might have led to
missing relevant publications. However, we believe that
checking of reference lists might have interfered with
our research question. Checking of reference lists would
only identify publications that were actually cited within
the network, while still missing relevant publications
that did not receive any citations.
Conclusion
Concluding, we found proof that citation bias is present
in the human literature on BPA. Publications that con-
cluded a harmful health effect of BPA are 1.5 times more
likely to be cited compared to negative publications. The
association between other determinants and the chance
of being cited is found to be hard to quantify since our
analysis was highly influenced by a low number of highly
cited publications. Nevertheless, journal impact factor
and author-related factors such as author’s authority and
self-citation show a consistent positive association with
the chance of being cited. With these findings, we could
conclude that the development of the available knowledge
on BPA seems to be mostly driven by authority-related
factors, instead of by the best available evidence.
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